Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rare Diseases × Data Collection × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 5 Pancreatic Neoplasms 3 Wilms Tumor 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Rare Diseases 1 Prostatic Neoplasms 1 Pancreatic Cyst 1 Ovarian Neoplasms 1 Neuromyelitis Optica 1 Neuroblastoma 1 Nervous System Neoplasms 1 Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 1 Myasthenia Gravis 1 Multiple Sclerosis 1 Multiple Myeloma 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Intestinal Neuroendocrine Tumor 1 Frailty 1 Financial Stress 1 Endometrial Neoplasms 1 Encephalomyelitis, Acute Disseminated 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Heavy Ion Radiotherapy 1 Data Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05773651 2024-10-01

STEP 2 0

University Hospital Tuebingen

10,000 enrolled

Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡